HOXA9 and acute myeloid leukemia: In AML, where dysregulation of MEIS1 and HoxA9 is repeatedly reported, forced co-expression of the two proteins significantly enhanced the tumourigenic properties of HoxA9, further highlighting a cooperative effect [66].